Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BENOXINATE HYDROCHLORIDE

BENOXINATE HYDROCHLORIDE

Standard Dose
0.4%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BENOXINATE HYDROCHLORIDE is listed in Drugs@FDA under application 084149 (ANDA).

Marketing status: Discontinued Active ingredient BENOXINATE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4% Sponsor SOLA BARNES HIND Submission history Latest submission status date: 1975-01-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview BENOXINATE HYDROCHLORIDE is listed in Drugs@FDA under application 084149 (ANDA). Marketing status: Discontinued Active ingredient BENOXINATE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.4% Sponsor SOLA BARNES HIND Submission history Latest submission status date: 1975-01-14 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BENOXINATE HYDROCHLORIDE (BENOXINATE HYDROCHLORIDE) | Drug Monograph | MedicHelpline